AU3153171A - Novel benzcyclobutene derivatives - Google Patents

Novel benzcyclobutene derivatives

Info

Publication number
AU3153171A
AU3153171A AU31531/71A AU3153171A AU3153171A AU 3153171 A AU3153171 A AU 3153171A AU 31531/71 A AU31531/71 A AU 31531/71A AU 3153171 A AU3153171 A AU 3153171A AU 3153171 A AU3153171 A AU 3153171A
Authority
AU
Australia
Prior art keywords
benzcyclobutene
derivatives
novel
novel benzcyclobutene
benzcyclobutene derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU31531/71A
Other languages
English (en)
Inventor
Harm Jan Hanneman Dr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Organon NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon NV filed Critical Organon NV
Publication of AU3153171A publication Critical patent/AU3153171A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/06—One of the condensed rings being a six-membered aromatic ring the other ring being four-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AU31531/71A 1970-08-07 1971-07-22 Novel benzcyclobutene derivatives Expired AU3153171A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL7011683A NL7011683A (enExample) 1970-08-07 1970-08-07
NLNL7011683 1970-08-07

Publications (1)

Publication Number Publication Date
AU3153171A true AU3153171A (en) 1973-01-25

Family

ID=19810731

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31531/71A Expired AU3153171A (en) 1970-08-07 1971-07-22 Novel benzcyclobutene derivatives

Country Status (9)

Country Link
US (1) US3804898A (enExample)
AU (1) AU3153171A (enExample)
BE (1) BE771055A (enExample)
CA (1) CA971970A (enExample)
DE (1) DE2139526A1 (enExample)
FR (1) FR2102106A1 (enExample)
HU (1) HU162459B (enExample)
NL (1) NL7011683A (enExample)
ZA (1) ZA714729B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013682A (en) * 1973-08-03 1977-03-22 Akzona Incorporated N-hydroxy-amidine compounds
NL7315350A (nl) * 1973-11-09 1975-05-13 Akzo Nv Nieuwe aminoguanidine verbindingen.
US4101675A (en) * 1973-11-09 1978-07-18 Akzona Incorporated Novel 2,6-di-substituted phenyl-aminoquanidine containing compositions and methods of using same and pharmaceutical compositions containing the same and therapeutic method
NL7407469A (nl) * 1974-06-01 1975-12-03 Akzo Nv Nieuwe amidinohydrazonverbindingen.
US5385946A (en) * 1986-07-10 1995-01-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Method for treating hypertension with disubstituted granidine compounds
US5312840A (en) * 1986-07-10 1994-05-17 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education Substituted guanidines having high binding to the sigma receptor and the use thereof
US5262568A (en) * 1990-03-02 1993-11-16 State Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5336689A (en) * 1990-03-02 1994-08-09 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
IE910719A1 (en) 1990-03-02 1991-09-11 Oregon State Tri- and tetra-substituted guanidines and their use as¹excitatory amino acid and antagonists
JPH05508836A (ja) * 1990-05-25 1993-12-09 オレゴン州 シグマ受容体に対して高い結合性を有する置換グアニジンおよびその使用
US5741661A (en) * 1991-02-08 1998-04-21 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
US5847006A (en) * 1991-02-08 1998-12-08 Cambridge Neuroscience, Inc. Therapeutic guanidines
EP0940139B1 (en) * 1991-02-08 2005-02-02 Scion Pharmaceuticals, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
JP3610368B2 (ja) * 1993-05-27 2005-01-12 セネス リミティド 治療用置換グアニジン
WO1995014461A1 (en) * 1993-11-23 1995-06-01 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
EP0738149B1 (en) * 1994-01-10 2006-11-29 Teva Pharmaceutical Industries, Ltd. 1-aminoindan derivatives and compositions thereof
US5914349A (en) 1994-01-10 1999-06-22 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
AU1912595A (en) * 1994-02-03 1995-08-21 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6787569B1 (en) 1994-02-03 2004-09-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US7351743B1 (en) 1994-02-03 2008-04-01 Wyeth Therapeutic guanidines
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6025355A (en) * 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) * 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
CA2275425C (en) 1996-12-18 2009-08-04 Michael Chorev Aminoindan derivatives
US6737547B1 (en) 1998-12-31 2004-05-18 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using N-acyl-1H-aminoindenes
US20040010038A1 (en) * 2002-02-27 2004-01-15 Eran Blaugrund Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
US20070135518A1 (en) * 2005-12-09 2007-06-14 Marta Weinstock-Rosin Use of low-dose ladostigil for neuroprotection
JP2009518433A (ja) * 2005-12-09 2009-05-07 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム 神経保護用の低用量ラドスチギルの使用
TW200744576A (en) * 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof

Also Published As

Publication number Publication date
BE771055A (nl) 1971-12-16
US3804898A (en) 1974-04-16
CA971970A (en) 1975-07-29
HU162459B (enExample) 1973-02-28
FR2102106A1 (fr) 1972-04-07
NL7011683A (enExample) 1972-02-09
ZA714729B (en) 1972-04-26
DE2139526A1 (enExample) 1972-03-09

Similar Documents

Publication Publication Date Title
CA971970A (en) Benzcyclobutene derivatives
AU451793B2 (en) Pyridoquinoline derivatives
AU453008B2 (en) Triazolobenzodiazepine derivatives
AU466630B2 (en) Ergolene derivatives
AU444009B2 (en) Triazolobenzodiazepine 5n-oxide derivatives
CA1014574A (en) Phenylisopropylamine derivatives
AU467958B2 (en) Novel n-alkenyltetracycline derivatives
AU446117B2 (en) Dihydropyrimidopyridazine derivatives
AU439043B2 (en) Puridazone derivatives
AU442249B2 (en) Terahydrocyclopropadibenzazepine derivatives
AU444748B2 (en) Aryloxyalkylmorpholine derivatives
AU448024B2 (en) Phenylaklane derivatives
AU462056B2 (en) Indenopyrrole derivatives
AU448194B2 (en) Dibenzothiopene derivatives
AU456187B2 (en) Benzocycloheptaisoquinoline derivatives
AU443255B2 (en) Evomonoside derivatives
AU448291B2 (en) Bornanamine derivatives
AU3306971A (en) Leucauramine derivatives
AU2648271A (en) 2-amino-imidazol-2-ine derivatives
CA843968A (en) 2-alkylthiophen derivatives
CA841046A (en) Piperidinoalkanol derivatives
CA845126A (en) Indole-3-ethanol derivatives
CA833558A (en) Sulfonyloxymorphinan derivatives
CA845138A (en) Nitrofuryl-oxadiazole derivatives
CA837137A (en) Penta-chlorobenzylidenamine derivatives